Zentalis Pharmaceuticals ZNTL Institutional Ownership

NASDAQ ZNTL

$3.59 -0.21 (-5.53%)

At close: Sep 10, 2026 · 4:00 PM EDT

Institutions by Trading Activity

116 Institutions

Increased 65 56.0%

Unchanged 19 16.4%

Reduced 32 27.6%

Ownership Statistics

13F · as of 30 Jun, 2026

Institutional Ownership

66.67%

▲+4.61 pp QoQ

Shares Held by Institutions

47.56Mn

of 71.33Mn outstanding

▲+14.04% QoQ

Shares Outstanding

71.33Mn

23.77Mn held outside 13F filers

Institutional Investors

116

filed 13F for Jun 2026

▲+14 vs prior quarter

Net Shares Added (QoQ)

+5.86Mn

accumulated since last quarter

Value of Holdings

$189.75Mn

reported market value

Shares Owned by Institutions

Shares held % of outstanding

Latest —

Average ownership —

Peak ownership —

Shares Purchased/Sold by Institutions

Accumulated Distributed

Latest quarter —

Net over range —

Accumulating quarters —

Ownership Summary

Quarter ending 30 Jun, 2026

Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL) is held by 116 institutional investors per 13F filings through June 2026.

These investors collectively held 66.7% of Zentalis Pharmaceuticals's outstanding shares in June 2026, up from 62.1% in March 2026.
Their total shares held in ZNTL increased 14.04% from the prior quarter, while the number of investors in Zentalis Pharmaceuticals stayed flat year over year.
Of these 116 funds, 65 grew their exposure to Zentalis Pharmaceuticals, 32 cut back, and 19 maintained positions.
In total, institutional investors held 47.56Mn shares in Zentalis Pharmaceuticals as of June 2026, up by 5.86Mn shares quarter on quarter, and down 8.56Mn shares year over year.
As of June 30, 2026, 5AM Venture Management, LLC held the largest stake in Zentalis Pharmaceuticals with 3.95Mn shares, accounting for 5.54% of total shares outstanding.
Top purchasers of ZNTL stock for the quarter ending June 2026 included BlackRock, Inc. (2.48Mn), ORBIMED ADVISORS LLC (1.39Mn), Soleus Capital Management, L.P. (950.0K), GEODE CAPITAL MANAGEMENT, LLC (663.08K), State Street Corp (637.73K).
The largest sellers of Zentalis Pharmaceuticals for the quarter ending June 2026 were D. E. Shaw & Co., Inc. (937.53K), MILLENNIUM MANAGEMENT LLC (625.54K), JANE STREET GROUP, LLC (475.94K), BNP PARIBAS FINANCIAL MARKETS (458.96K), Barclays Plc (432.36K).
Per Business Quant data, the top 10 holders of Zentalis Pharmaceuticals for the quarter ending June 2026 are 5AM Venture Management, LLC (3.95Mn), BlackRock, Inc. (3.75Mn), Squadron Capital Management LLC (3.7Mn), TWO SIGMA INVESTMENTS, LP (3.02Mn), VANGUARD CAPITAL MANAGEMENT LLC (2.84Mn), ACADIAN ASSET MANAGEMENT LLC (2.68Mn), CITADEL ADVISORS LLC (2.3Mn), RENAISSANCE TECHNOLOGIES LLC (1.61Mn), Opaleye Management Inc. (1.41Mn), ORBIMED ADVISORS LLC (1.39Mn).

Form 13F Holdings

116 Institutional Holders

Report period 30 Jun, 2026

Total shares held 47.56Mn

Of outstanding 66.67%

#	Institution	CIK	Shares Held	% of Outstanding	Change (QoQ)	Change (%)	Value (USD)
1	5AM Venture Management, LLC	0001799883	3,947,913	5.54%	0	0.00%	$19.15Mn
2	BlackRock, Inc.	0002012383	3,753,525	5.26%	▲2,483,688	+195.59%	$18.20Mn
3	Squadron Capital Management LLC	0002050709	3,700,000	5.19%	▲69,000	+1.90%	$17.95Mn
4	TWO SIGMA INVESTMENTS, LP	0001179392	3,024,936	4.24%	▲68,410	+2.31%	$14.67Mn
5	VANGUARD CAPITAL MANAGEMENT LLC	0002100119	2,835,669	3.98%	▲524,962	+22.72%	$13.75Mn
6	ACADIAN ASSET MANAGEMENT LLC	0000916542	2,681,900	3.76%	▼166,352	-5.84%	$13.00K
7	CITADEL ADVISORS LLC	0001423053	2,298,403	3.22%	▲566,320	+32.70%	$11.15Mn
8	RENAISSANCE TECHNOLOGIES LLC	0001037389	1,609,078	2.26%	▼329,067	-16.98%	$7.80Mn
9	Opaleye Management Inc.	0001595855	1,412,656	1.98%	0	0.00%	$6.85Mn
10	ORBIMED ADVISORS LLC	0001055951	1,390,576	1.95%	▲1,390,576	0.00%	$6.74Mn
11	Decheng Capital LLC	0002010850	1,323,327	1.86%	0	0.00%	$6.42Mn
12	GEODE CAPITAL MANAGEMENT, LLC	0001214717	1,284,117	1.80%	▲663,081	+106.77%	$6.23Mn
13	Bank Of America Corp /De/	0000070858	1,114,650	1.56%	▼17,644	-1.56%	$5.41Mn
14	Ishara Investments LP	0002111609	1,025,000	1.44%	▼205,000	-16.67%	$4.97Mn
15	PRIMECAP MANAGEMENT CO/CA/	0000763212	957,420	1.34%	0	0.00%	$4.64Mn
16	Pfizer Inc	0000078003	953,834	1.34%	0	0.00%	$3.85Mn
17	Soleus Capital Management, L.P.	0001802630	950,000	1.33%	▲950,000	0.00%	$4.61Mn
18	State Street Corp	0000093751	887,416	1.24%	▲637,726	+255.41%	$4.30Mn
19	VANGUARD PORTFOLIO MANAGEMENT LLC	0002100121	808,548	1.13%	▲447,948	+124.22%	$3.92Mn
20	Connor, Clark & Lunn Investment Management Ltd.	0001596800	758,033	1.06%	▼33,968	-4.29%	$3.68Mn

Showing 1 to 20 of 116 holders